It has been a turbulent time for the pharmaceutical industry – especially in regard to the clinical trial sector. From reduced investment, to a lack of public trust in the industry, it has been ...

How pharma–hospital partnerships can overcome operational, financial, and organizational barriers to build high-performing clinical trial programs that expand access, accelerate accrual, and ...

More than 74,000 people have had their lives disrupted by Trump administration cuts to clinical trials supported by the ...

Credit: Getty Images Clinical trial investigators explore the headway made by diversity, equity, and inclusion initiatives in clinical trials of Alzheimer disease and related dementias and the ...

The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...

Credit: Getty Images. Patients from racial and ethnic minority groups are still underrepresented in cancer research, despite efforts to make clinical trials more diverse. Patients from racial and ...

In a recent study published in The Lancet Infectious Diseases, scientists reviewed the history of using human challenge trials in developing vaccines. The study explored vaccine development for 19 ...

The governing ethics committee and regulatory agency have met on the study protocol and plan to issue their response in Q4; AIM anticipates that the trial will commence shortly thereafter OCALA, Fla., ...

WASHINGTON — Members of a government ethics panel have renewed their criticisms of a controversial study in which volunteers are to be deliberately infected with the Zika virus. In an article ...

Regeneron (REGN) announced results evaluating its nvestigational allergen-blocking antibodies in allergen-challenge Phase 3 trials in adults with moderate-to-severe cat or birch allergies. Both trials ...